Monte Rosa Therapeutics Inc (NAS:GLUE)
$ 21.97 -1.04 (-4.52%) Market Cap: 1.86 Bil Enterprise Value: 1.23 Bil PE Ratio: 0 PB Ratio: 3.55 GF Score: 34/100

Monte Rosa Therapeutics Inc at TD Cowen Oncology Innovation Summit (Virtual) Transcript

May 27, 2026 / 04:00 PM GMT
Release Date Price: $19.17 (-0.16%)


Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

GLUE.OQ - Monte Rosa Therapeutics Inc
Monte Rosa Therapeutics Inc at TD Cowen Oncology Innovation Summit (Virtual)
May 27, 2026 / 04:00PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
All right. Thanks, everyone, for joining for the next session of TD Cowan's Oncology Innovation Summit. I'm Mark Fraham from the Biotech team here at TD Cowan. And we're really pleased to have joining us for the next session, the CMO from Monte Rosa, Philip Jinku, where we will be talking about the. The full range of their pipeline, which does go beyond oncology, although given this is an oncology-focused event, we will spend probably a bit more time than is often done on the oncology assets and we'll kind of lead off with those.

And I have a whole list of questions that I and my team have come up with to go through, but we do want to make this interactive. So for the investors on the
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot